Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
出版年份 2020 全文链接
标题
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
作者
关键词
-
出版物
JOURNAL OF HEADACHE AND PAIN
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-07
DOI
10.1186/s10194-020-01102-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab: from scientific evidence to clinical practice—the first Italian real-life data
- (2019) Piero Barbanti et al. NEUROLOGICAL SCIENCES
- Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence
- (2019) T. J. Steiner et al. JOURNAL OF HEADACHE AND PAIN
- How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
- (2019) Cindy Tiseo et al. JOURNAL OF HEADACHE AND PAIN
- Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
- (2019) Paolo Martelletti et al. JOURNAL OF HEADACHE AND PAIN
- Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications
- (2019) Thomas Dresler et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab in chronic migraine with medication overuse
- (2019) Stewart J. Tepper et al. NEUROLOGY
- Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
- (2019) Messoud Ashina et al. CEPHALALGIA
- Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions
- (2019) Messoud Ashina et al. CEPHALALGIA
- The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal
- (2019) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Migraine is first cause of disability in under 50s: will health politicians now take notice?
- (2018) Timothy J. Steiner et al. JOURNAL OF HEADACHE AND PAIN
- The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
- (2018) HEADACHE
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
- (2018) Uwe Reuter et al. LANCET
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month
- (2016) M Torres-Ferrús et al. CEPHALALGIA
- The therapeutic armamentarium in migraine is quite elderly
- (2014) Paolo Martelletti Expert Opinion on Drug Metabolism & Toxicology
- Allodynia and migraine
- (2012) Marco Aguggia NEUROLOGICAL SCIENCES
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Adherence with Migraine Prophylaxis in Clinical Practice
- (2012) Ariel Berger et al. Pain Practice
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- CGRP receptor antagonism and migraine
- (2010) Lars Edvinsson et al. Neurotherapeutics
- Are Migraineurs at Increased Risk of Adverse Drug Responses?: A Meta-Analytic Comparison of Topiramate-Related Adverse Drug Reactions in Epilepsy and Migraine
- (2008) J Luykx et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started